Zydus Lifesciences (India) Today
| ZYDUSLIFE | 923.90 24.60 2.74% |
PerformanceVery Weak
| Odds Of DistressVery Small
|
Zydus Lifesciences is trading at 923.90 as of the 17th of February 2025. This is a 2.74 percent increase since the beginning of the trading day. The stock's open price was 899.3. Zydus Lifesciences has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of February 2023 and ending today, the 17th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Zydus Lifesciences is entity of India. It is traded as Stock on NSE exchange. The company has 1.01 B outstanding shares. More on Zydus Lifesciences Limited
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Zydus Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Zydus Lifesciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Zydus Lifesciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President America | Punit Patel | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) | ||||
Zydus Lifesciences' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Zydus Lifesciences' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsZydus Lifesciences can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Zydus Lifesciences' financial leverage. It provides some insight into what part of Zydus Lifesciences' total assets is financed by creditors.
| |||||
Zydus Lifesciences Limited (ZYDUSLIFE) is traded on National Stock Exchange of India in India and employs 26,921 people. Zydus Lifesciences is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 907.47 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zydus Lifesciences's market, we take the total number of its shares issued and multiply it by Zydus Lifesciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Zydus Lifesciences operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 1.01 B outstanding shares.
Zydus Lifesciences generates positive cash flow from operations, but has no cash available
Check Zydus Lifesciences Probability Of Bankruptcy
Ownership AllocationZydus Lifesciences Limited retains a total of 1.01 Billion outstanding shares. Zydus Lifesciences maintains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 75.15 (%) of Zydus Lifesciences outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Zydus Ownership Details
Zydus Lifesciences Risk Profiles
Although Zydus Lifesciences' alpha and beta are two of the key measurements used to evaluate Zydus Lifesciences' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.37 | |||
| Standard Deviation | 1.68 | |||
| Variance | 2.83 | |||
| Risk Adjusted Performance | (0.03) |
Zydus Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Zydus Lifesciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Zydus Lifesciences Corporate Management
Elected by the shareholders, the Zydus Lifesciences' board of directors comprises two types of representatives: Zydus Lifesciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zydus. The board's role is to monitor Zydus Lifesciences' management team and ensure that shareholders' interests are well served. Zydus Lifesciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zydus Lifesciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dhaval Soni | Company Officer | Profile | |
| Nitinkumar Parekh | Chief Officer | Profile | |
| Arvind Bothra | Head Relations | Profile | |
| Vishal Gor | Vice Cadila | Profile |
Other Information on Investing in Zydus Stock
Zydus Lifesciences financial ratios help investors to determine whether Zydus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zydus with respect to the benefits of owning Zydus Lifesciences security.